GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Infectious Diseases

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/infdis/jir769PMID 22147791PMCID PMC3256953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

  2011cited by this paper
• Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant

  2011cited by this paper
• Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans.

  2011cited by this paper
• Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4(+) T cells during ageing

  2010cited by this paper
• Clinical and immunologic predictors of influenza illness among vaccinated older adults.

  2010cited by this paper
• Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

  2010influential reference
• Differential activation and maturation of two porcine DC populations following TLR ligand stimulation.

  2010cited by this paper
• TLR-Activated Dendritic Cells Enhance the Response of Aged Naive CD4 T Cells via an IL-6–Dependent Mechanism

  2010cited by this paper
• A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines

  2010cited by this paper
• Standardization and validation of assays determining cellular immune responses against influenza.

  2010cited by this paper
• Neonatal Innate TLR-Mediated Responses Are Distinct from Those of Adults1

  2009cited by this paper
• Decreased TNF-α synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging

  2009cited by this paper
• Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults.

  2009cited by this paper
• Increased Reactivity of Dendritic Cells from Aged Subjects to Self-Antigen, the Human DNA1

  2009cited by this paper
• Influenza control in the 21st century: Optimizing protection of older adults.

  2009cited by this paper
• Immunosenescence and Influenza Vaccine Efficacy

  2009cited by this paper
• Multiple signaling pathways contribute to synergistic TLR ligand‐dependent cytokine gene expression in human monocyte‐derived macrophages and dendritic cells

  2009cited by this paper
• A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro.

  2009cited by this paper
• Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsions.

  2008cited by this paper
• CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.

  2007cited by this paper
• Altered Innate Immune Functioning of Dendritic Cells in Elderly Humans: A Role of Phosphoinositide 3-Kinase-Signaling Pathway1

  2007cited by this paper
• Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans.

  2007cited by this paper
• T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly1

  2006cited by this paper
• Murine [corrected] myeloid dendritic cell-dependent toll-like receptor immunity is preserved with aging.

  2006cited by this paper
• Nurine myeloid dendritic cell‐dependent toll‐like receptor immunity is preserved with aging

  2006cited by this paper
• A pathway analysis of poly(I:C)-induced global gene expression change in human peripheral blood mononuclear cells.

  2006cited by this paper
• The effect of aging on cognate function and development of immune memory.

  2005cited by this paper
• Inflammatory Cytokines Overcome Age-Related Defects in CD4 T Cell Responses In Vivo1

  2004cited by this paper
• Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents

  2004cited by this paper
• Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R).

  2003cited by this paper
• TNF-α-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection

  2001cited by this paper
• Chronological ageing and photoageing of dendritic cells

  2001cited by this paper
• Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells.

  2000cited by this paper
• Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species.

  1999cited by this paper
• The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1.

  1999cited by this paper
• Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals

  1996cited by this paper
• Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.

  1994cited by this paper

• Influenza Vaccines: Current Status, Adjuvant Strategies, and Efficacy

  2025cites this paper
• Novel Strategies for Developing Next-Generation Vaccines to Combat Infectious Viral Diseases

  2025cites this paper
• Immune Aging, Immunosenescence, and Inflammaging: Implications for Vaccine Response in Older Adults

  2025cites this paper
• Subunit antigen delivery: emulsion and liposomal adjuvants for next-generation vaccines

  2025cites this paper
• The Design and Prospects of Influenza Virus Vaccines Based on Conserved Epitopes and Adjuvant Optimization

  2025cites this paper
• Adjuvants and MHCII modulate the immunogenicity of subdominant epitopes in Plasmodium vivax Duffy binding protein

  2025cites this paper
• Recent Insights into the Molecular Mechanisms of the Toll-like Receptor Response to Influenza Virus Infection

  2024cites this paper
• Randomized, observer-blind, controlled Phase 1 study of the safety and immunogenicity of the Na-GST-1/Alhydrogel hookworm vaccine with or without a CpG ODN adjuvant in hookworm-naïve adults

  2024cites this paper
• HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines

  2024cites this paper
• Ally, adversary, or arbitrator? The context-dependent role of eosinophils in vaccination for respiratory viruses and subsequent breakthrough infections

  2024cites this paper
• Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease

  2024cites this paper
• An assessment of a GMP schistosomiasis vaccine (SchistoShield®)

  2024cites this paper
• Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans

  2023cites this paper
• In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives

  2023cites this paper
• Carbohydrate fatty acid monosulphate ester is a potent adjuvant for low-dose seasonal influenza vaccines.

  2023cites this paper
• TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview

  2023cites this paper
• Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice

  2023cites this paper
• Advances in vaccine delivery strategies to promote effective immunization

  2022cites this paper
• Advances in Infectious Disease Vaccine Adjuvants

  2022cites this paper
• Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population

  2021cites this paper
• “World in motion” – emulsion adjuvants rising to meet the pandemic challenges

  2021cites this paper
• Influenza Vaccination in Older Adults

  2021cites this paper
• Vaccines and Vaccination Strategies for Older Adults

  2021cites this paper
• Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines.

  2021cites this paper
• The impact of immuno-aging on SARS-CoV-2 vaccine development

  2021cites this paper
• Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity

  2021cites this paper
• A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development.

  2021cites this paper
• Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults

  2021cites this paper
• Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment

  2020cites this paper
• Vaccination of aged mice with adjuvanted recombinant influenza nucleoprotein enhances protective immunity.

  2020cites this paper
• The immune response to influenza in older humans: beyond immune senescence

  2020cites this paper
• Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant–Antigen Codelivery

  2020cites this paper
• Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization

  2020cites this paper
• Adjuvant Option for Effective SARS-CoV-2 Vaccine

  2020cites this paper
• Views of the physicians of different specialities on the vaccination: concerns and expectations

  2020cites this paper
• Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly

  2020cites this paper
• Emerging Concepts and Technologies in Vaccine Development

  2020cites this paper
• Operative Trauma and Blood Loss - Impact on Tumor Growth and Recurrence.

  2020cites this paper
• Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants

  2020cites this paper
• Innate sensors that regulate vaccine responses.

  2019cites this paper
• Influenza Vaccination in Older Adults

  2019cites this paper
• Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines

  2019cites this paper
• Zoster vaccination in older adults: efficacy and public health implications.

  2019cites this paper
• In vitro and in vivo inhibitory effects of TLR4 agonist, glucopyranosyl lipid A (GLA), on allergic rhinitis caused by Japanese cedar pollen

  2019cites this paper
• Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses.

  2019cites this paper
• Vaccination with synthetic long peptide formulated with CpG in an oil-in-water emulsion induces robust E7-specific CD8 T cell responses and TC-1 tumor eradication

  2019cites this paper
• Deleterious synergistic effects of distress and surgery on cancer metastasis: Abolishment through an integrated perioperative immune-stimulating stress-inflammatory-reducing intervention.

  2019cites this paper
• Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial

  2018cites this paper
• The adjuvant GLA-AF enhances human intradermal vaccine responses

  2018cites this paper
• Adjuvants.

  2018cites this paper
• Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques

  2018cites this paper
• Vaccine and immune cell therapy in non-small cell lung cancer.

  2018cites this paper
• Effect of 2 Emulsion-Based Adjuvants on the Structure and Thermal Stability of Staphylococcus aureus Alpha-Toxin.

  2018cites this paper
• Compromised T cell Immunity in Elderly via Naïve T cell Anergy

  2018cites this paper
• Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection

  2018cites this paper
• Adjuvant strategies to improve vaccination of the elderly population

  2018cites this paper
• Schistosomiasis Vaccine Development: The Missing Link

  2017cites this paper
• Pattern recognition receptor immunomodulation of innate immunity as a strategy to limit the impact of influenza virus

  2017cites this paper
• Frequencies of peripheral immune cells in older adults following seasonal influenza vaccination with an adjuvanted vaccine.

  2017cites this paper
• CD8+ memory T-cell inflation renders compromised CD4+ T-cell-dependent CD8+ T-cell immunity via naïve T-cell anergy

  2017cites this paper
• Influenza vaccine‐mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage

  2017cites this paper
• Feasibility of Freeze-Drying Oil-in-Water Emulsion Adjuvants and Subunit Proteins to Enable Single-Vial Vaccine Drug Products.

  2017cites this paper
• A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens

  2017cites this paper
• Personalized vaccinology: A review

  2017cites this paper
• Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis

  2017cites this paper
• Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection

  2017cites this paper
• Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons

  2017cites this paper
• An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators

  2017cites this paper
• CD 8 + memory T-cell inflation renders compromised CD 4 + T-cell-dependent CD 8 + T-cell immunity via naïve T-cell anergy

  2017cites this paper
• Subtle Morbidity in Schistosomiasis

  2017cites this paper
• Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model.

  2017cites this paper
• Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison

  2017cites this paper
• Summary and discussion

  2017cites this paper
• Vaccinology: The art of putting together the right ingredients

  2016cites this paper
• Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination

  2016cites this paper
• The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old age

  2016cites this paper
• Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults.

  2016cites this paper
• Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients.

  2016cites this paper
• Exploiting Mucosal Immunity for Antiviral Vaccines.

  2016cites this paper
• IL-2 and IL-6 cooperate to enhance the generation of influenza-specific CD8 T cells responding to live influenza virus in aged mice and humans

  2016cites this paper
• IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants

  2016cites this paper
• CpG-mediated augmentation of CD8+ T-cell responses in mice is attenuated by a water-in-oil emulsion (Montanide ISA-51) but enhanced by an oil-in-water emulsion (IDRI SE).

  2016cites this paper
• New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for Influenza

  2016cites this paper
• T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines

  2016cites this paper
• Molecular characteristics and potential therapeutic targets in Merkel cell carcinoma

  2016cites this paper
• Vaccine Self-Assembling Immune Matrix Is a New Delivery Platform That Enhances Immune Responses to Recombinant HBsAg in Mice

  2015cites this paper
• Emulsions as Vaccine Adjuvants

  2015cites this paper
• Trial Watch: Peptide-based anticancer vaccines

  2015cites this paper
• Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants

  2015cites this paper
• A Novel Respiratory Syncytial Virus (RSV) F Subunit Vaccine Adjuvanted with GLA-SE Elicits Robust Protective TH1-Type Humoral and Cellular Immunity In Rodent Models

  2015cites this paper
• A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation

  2015cites this paper
• Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques.

  2015cites this paper
• Immunisation with recombinant polymorphic membrane protein D elicits robust protection against sexually transmitted Chlamydia trachomatis infection

  2015cites this paper
• Exploiting the critical perioperative period to improve long-term cancer outcomes

  2015cites this paper
• From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE

  2015cites this paper
• Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.

  2015cites this paper
• Immunosenescence: implications for vaccination programs in the elderly

  2015cites this paper
• Inactivated and adjuvanted influenza vaccines.

  2015cites this paper
• Impaired heterologous immunity in aged ferrets during sequential influenza A H1N1 infection.

  2014cites this paper
• Determinantes en el balance eficacia-toxicidad de las acunas contemporáneas lexander

  2014cites this paper